Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 13-Dec-23 1:40 PM View:  | Quinn William P. Chief Financial Officer | Bolt Biotherapeutics, Inc. (BOLT) | 12-Dec-23 | Purchase | 7,500 | $0.95 | $7,125.00 | 26% 28.77K to 36.27K | |
| 06-Feb-24 10:00 PM View: | Schatzman Randall C Chief Executive Officer Director | Bolt Biotherapeutics, Inc. (BOLT) | 06-Dec-23 | Purchase | 2,500 | $0.78 | $1,955.00 | 24% 10.36K to 12.86K | |
| 06-Feb-24 10:00 PM View: | Perez Edith A. Chief Medical Officer | Bolt Biotherapeutics, Inc. (BOLT) | 06-Dec-23 | Purchase | 2,500 | $0.78 | $1,955.00 | 6% 44.11K to 46.61K | |
| 13-Dec-23 1:40 PM View: | Quinn William P. Chief Financial Officer | Bolt Biotherapeutics, Inc. (BOLT) | 06-Dec-23 | Purchase | 2,500 | $0.78 | $1,955.00 | 10% 26.27K to 28.77K | |
| 06-Feb-24 10:00 PM View: | Yonehiro Grant Chief Business Officer | Bolt Biotherapeutics, Inc. (BOLT) | 06-Dec-23 | Private Purchase | 2,500 | $0.78 | $1,955.00 | 39% 6.42K to 8.92K | |
| 01-Dec-23 12:31 PM View: | Engleman Edgar Director | Bolt Biotherapeutics, Inc. (BOLT) | 30-Nov-23 | Sale | 123,079 | $0.86 | $105,614.00 | (6%) 2.2M to 2.07M | |
| 01-Dec-23 12:31 PM View: | Engleman Edgar Director | Bolt Biotherapeutics, Inc. (BOLT) | 29-Nov-23 | Sale | 25,805 | $0.91 | $23,379.30 | (1%) 2.22M to 2.2M | |
| 22-Nov-23 6:51 PM View: | Vivo Capital Viii, LLC 10% Owner | Bolt Biotherapeutics, Inc. (BOLT) | 21-Nov-23 | Sale | 3,400 | $0.90 | $3,060.00 | (< 1%) 3.79M to 3.78M | |
| 20-Nov-23 10:00 PM View: | Vivo Capital Viii, LLC 10% Owner | Bolt Biotherapeutics, Inc. (BOLT) | 20-Nov-23 | Sale | 54,700 | $0.92 | $50,324.00 | (< 1%) 7.81M to 7.76M | |
| 20-Nov-23 10:00 PM View: | Vivo Capital Viii, LLC 10% Owner | Bolt Biotherapeutics, Inc. (BOLT) | 17-Nov-23 | Sale | 16,354 | $0.93 | $15,209.20 | (< 1%) 7.83M to 7.81M | |
| 20-Nov-23 10:00 PM View: | Vivo Capital Viii, LLC 10% Owner | Bolt Biotherapeutics, Inc. (BOLT) | 16-Nov-23 | Sale | 15,000 | $0.96 | $14,400.00 | (< 1%) 7.84M to 7.83M | |
| 06-Feb-24 10:00 PM View: | Perez Edith A. Chief Medical Officer | Bolt Biotherapeutics, Inc. (BOLT) | 06-Jun-23 | Private Purchase | 2,070 | $1.18 | $2,445.70 | 5% 42.04K to 44.11K | |
| 13-Dec-23 1:40 PM View: | Quinn William P. Chief Financial Officer | Bolt Biotherapeutics, Inc. (BOLT) | 06-Jun-23 | Private Purchase | 1,829 | $1.18 | $2,160.96 | 7% 24.44K to 26.27K | |
| 06-Feb-24 10:00 PM View: | Schatzman Randall C Chief Executive Officer Director | Bolt Biotherapeutics, Inc. (BOLT) | 06-Jun-23 | Private Purchase | 2,500 | $1.18 | $2,953.75 | 32% 7.86K to 10.36K | |
| 15-Jul-22 4:16 PM View: | Novo A/s 10% Owner | Bolt Biotherapeutics, Inc. (BOLT) | 13-Jul-22 | Sale | 800,000 | $2.00 | $1,600,000.00 | (18%) 4.5M to 3.7M | |
| 01-Feb-22 7:18 PM View: | Perez Edith A. Chief Medical Officer | Bolt Biotherapeutics, Inc. (BOLT) | 22-Dec-21 | Option Exercise | 35,714 | $2.80 | $99,999.20 | 2689% 1.33K to 37.04K | |
| 09-Dec-21 4:05 PM View: | Quinn William P. Chief Financial Officer | Bolt Biotherapeutics, Inc. (BOLT) | 08-Dec-21 | Purchase | 5,000 | $4.72 | $23,575.00 | 33% 15.15K to 20.15K | |
| 01-Feb-22 7:18 PM View: | Perez Edith A. Chief Medical Officer | Bolt Biotherapeutics, Inc. (BOLT) | 06-Dec-21 | Purchase | 411 | $4.64 | $1,907.04 | 45% 0.92K to 1.33K | |
| 09-Dec-21 4:05 PM View: | Quinn William P. Chief Financial Officer | Bolt Biotherapeutics, Inc. (BOLT) | 06-Dec-21 | Purchase | 35 | $4.64 | $162.40 | < 1% 15.12K to 15.15K | |
| 09-Dec-21 4:05 PM View: | Quinn William P. Chief Financial Officer | Bolt Biotherapeutics, Inc. (BOLT) | 04-Jun-21 | Private Purchase | 1,221 | $16.65 | $20,329.70 | 9% 13.9K to 15.12K | |
| 01-Feb-22 7:18 PM View: | Perez Edith A. Chief Medical Officer | Bolt Biotherapeutics, Inc. (BOLT) | 04-Jun-21 | Private Purchase | 917 | $16.65 | $15,268.00 | 100% 0 to 0.92K | |
| 09-Feb-21 6:04 PM View: | Sofinnova Venture Partners ... 10% Owner | Bolt Biotherapeutics, Inc. (BOLT) | 09-Feb-21 | Conversion | 2,304,440 | -- | -- | 100% 0 to 2.3M | |
| 09-Feb-21 3:23 PM View: | Quinn William P. Chief Financial Officer | Bolt Biotherapeutics, Inc. (BOLT) | 09-Feb-21 | Purchase | 1,200 | $20.00 | $24,000.00 | 9% 12.7K to 13.9K | |
| 09-Feb-21 3:27 PM View: | Khanna Ashish Siri Ram Director | Bolt Biotherapeutics, Inc. (BOLT) | 09-Feb-21 | Purchase Duplicate | 1,200 | $20.00 | $24,000.00 | 120% 1.0K to 2.2K | |
| 09-Feb-21 3:37 PM View: | Vivo Capital Viii, LLC 10% Owner | Bolt Biotherapeutics, Inc. (BOLT) | 09-Feb-21 | Purchase | 350,000 | $20.00 | $7,000,000.00 | 10% 3.46M to 3.81M | |
| 09-Feb-21 3:25 PM View: | Engleman Edgar Director 10% Owner | Bolt Biotherapeutics, Inc. (BOLT) | 09-Feb-21 | Sale | 164 | $20.00 | $3,280.00 | (< 1%) 3.49M to 3.49M | |
| 09-Feb-21 3:25 PM View: | Engleman Edgar Director 10% Owner | Bolt Biotherapeutics, Inc. (BOLT) | 09-Feb-21 | Exercise (in-the money or at-the-money) | 46,608 | $0.07 | $3,262.56 | 1% 3.45M to 3.49M | |
| 09-Feb-21 3:33 PM View: | Shah Mahendra Director | Bolt Biotherapeutics, Inc. (BOLT) | 09-Feb-21 | Conversion | 1,416,350 | -- | -- | 9915% 14.29K to 1.43M | |
| 11-Feb-21 4:39 PM View: | Novo A/s 10% Owner | Bolt Biotherapeutics, Inc. (BOLT) | 09-Feb-21 | Conversion | 4,027,090 | -- | -- | 5237% 76.9K to 4.1M | |
| 09-Feb-21 3:25 PM View: | Engleman Edgar Director 10% Owner | Bolt Biotherapeutics, Inc. (BOLT) | 09-Feb-21 | Purchase | 200,000 | $20.00 | $4,000,000.00 | 6% 3.25M to 3.45M | |
| 09-Feb-21 3:29 PM View: | Healy James Director | Bolt Biotherapeutics, Inc. (BOLT) | 09-Feb-21 | Purchase Duplicate | 450,000 | $20.00 | $9,000,000.00 | 10% 4.61M to 5.06M | |
| 09-Feb-21 6:04 PM View: | Sofinnova Venture Partners ... 10% Owner | Bolt Biotherapeutics, Inc. (BOLT) | 09-Feb-21 | Purchase | 450,000 | $20.00 | $9,000,000.00 | 20% 2.3M to 2.75M | |
| 09-Feb-21 3:33 PM View: | Shah Mahendra Director | Bolt Biotherapeutics, Inc. (BOLT) | 09-Feb-21 | Sale | 62 | $20.00 | $1,240.00 | (< 1%) 1.45M to 1.45M | |
| 09-Feb-21 3:33 PM View: | Shah Mahendra Director | Bolt Biotherapeutics, Inc. (BOLT) | 09-Feb-21 | Exercise (in-the money or at-the-money) | 17,711 | $0.07 | $1,239.77 | 1% 1.43M to 1.45M | |
| 09-Feb-21 3:25 PM View: | Engleman Edgar Director 10% Owner | Bolt Biotherapeutics, Inc. (BOLT) | 09-Feb-21 | Conversion | 1,997,990 | -- | -- | 160% 1.25M to 3.25M | |
| 09-Feb-21 3:37 PM View: | Vivo Capital Viii, LLC 10% Owner | Bolt Biotherapeutics, Inc. (BOLT) | 09-Feb-21 | Conversion | 3,414,340 | -- | -- | 7967% 42.86K to 3.46M | |
| 09-Feb-21 3:20 PM View: | Schatzman Randall C Chief Executive Officer Director | Bolt Biotherapeutics, Inc. (BOLT) | 09-Feb-21 | Purchase | 1,500 | $20.00 | $30,000.00 | 100% 0 to 1.5K | |
| 09-Feb-21 3:27 PM View: | Khanna Ashish Siri Ram Director | Bolt Biotherapeutics, Inc. (BOLT) | 09-Feb-21 | Purchase | 1,000 | $20.00 | $20,000.00 | 100% 0 to 1.0K | |
| 09-Feb-21 3:35 PM View: | Laporte Kathleen Director | Bolt Biotherapeutics, Inc. (BOLT) | 09-Feb-21 | Purchase | 1,200 | $20.00 | $24,000.00 | 100% 0 to 1.2K | |
| 11-Feb-21 4:39 PM View: | Novo A/s 10% Owner | Bolt Biotherapeutics, Inc. (BOLT) | 09-Feb-21 | Purchase | 400,000 | $20.00 | $8,000,000.00 | 10% 4.1M to 4.5M | |
| 09-Feb-21 3:37 PM View: | Vivo Capital Viii, LLC 10% Owner | Bolt Biotherapeutics, Inc. (BOLT) | 09-Feb-21 | Sale | 226 | $20.00 | $4,520.00 | (< 1%) 3.87M to 3.87M | |
| 09-Feb-21 3:37 PM View: | Vivo Capital Viii, LLC 10% Owner | Bolt Biotherapeutics, Inc. (BOLT) | 09-Feb-21 | Exercise (in-the money or at-the-money) | 64,319 | $0.07 | $4,502.33 | 2% 3.81M to 3.87M | |
| 09-Feb-21 3:29 PM View: | Healy James Director | Bolt Biotherapeutics, Inc. (BOLT) | 09-Feb-21 | Conversion Duplicate | 2,304,440 | -- | -- | 100% 2.3M to 4.61M |
